Effect of salt intake on progression of chronic kidney disease

被引:34
作者
Sanders, PW
机构
[1] Univ Alabama, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[2] Univ Alabama, Comprehens Canc Ctr, Nephrol Res & Training Ctr, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL USA
[4] Dept Vet Affairs Med Ctr, Birmingham, AL USA
关键词
dietary salt; endothelium; nitric oxide; renal function; transforming growth factor-beta;
D O I
10.1097/01.mnh.0000186853.23512.a5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review: The attempt of this review is to bring into focus the potential role of dietary salt intake in progression of chronic kidney disease. Recent findings: Ongoing work has elucidated a role for dietary salt intake in modulating intrarenal production of transforming growth factor-beta 1. The mechanism is independent of angiotensin 11 and systemic blood pressure and involves activation of vascular endothelium by dietary salt intake with release of this growth factor. In this model, transforming growth factor-beta 1 serves an autacoid function by stimulating nitric oxide production by the endothelium. In turn, endothelium-derived nitric oxide modulates production of this growth factor. The model further predicts that individuals who have lost the requisite endothelial cell flexibility to adapt to this environmental stress (a high salt diet) are potentially at increased risk of developing end-organ damage from excess salt intake. Animal and human studies are presented to support this working hypothesis. Summary: Overproduction of transforming growth factor-beta 1 permits excess biological activity of this important fibrogenic growth factor with subsequent development or acceleration of vascular and kidney damage. In patients with diseases whose pathogenesis is related to excess production of transforming growth factor-beta 1, such as chronic allograft nephropathy and diabetic nephropathy, increased salt intake may hasten loss of function, particularly if nitric oxide production does not increase. The role that endothelial cell plasticity plays in altering vascular tone and renal function, especially in response to changes in dietary salt intake, should be examined further in chronic kidney disease.
引用
收藏
页码:54 / 60
页数:7
相关论文
共 64 条
[1]   Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels [J].
Agarwal, R ;
Siva, S ;
Dunn, SR ;
Sharma, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03) :486-492
[2]   Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis [J].
Akagi, Y ;
Isaka, Y ;
Arai, M ;
Kaneko, T ;
Takenaka, M ;
Moriyama, T ;
Kaneda, Y ;
Ando, A ;
Orita, Y ;
Kamada, T ;
Ueda, N ;
Imai, E .
KIDNEY INTERNATIONAL, 1996, 50 (01) :148-155
[3]   Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells [J].
Anderson, PW ;
Zhang, XY ;
Tian, J ;
Correale, JD ;
Xi, PX ;
Yang, D ;
Graf, K ;
Law, RE ;
Hsueh, WA .
KIDNEY INTERNATIONAL, 1996, 50 (03) :745-753
[4]   SUPERIORITY OF SALT RESTRICTION OVER DIURETICS IN REDUCING RENAL HYPERTROPHY AND INJURY IN UNINEPHRECTOMIZED SHR [J].
BENSTEIN, JA ;
FEINER, HD ;
PARKER, M ;
DWORKIN, LD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (06) :F1675-F1681
[5]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[6]   SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[7]   TGF-β signaling in renal disease [J].
Böttinger, EP ;
Bitzer, M .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10) :2600-2610
[9]   Salt intake and renal outcome in patients with progressive renal disease [J].
Cianciaruso, B ;
Bellizzi, V ;
Minutolo, R ;
Tavera, A ;
Capuano, A ;
Conte, G ;
De Nicola, L .
MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (04) :296-301